Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

DuPont reports strong Q3 earnings and progresses on strategic separations

DuPont's Q3 earnings call reflects a robust performance with growth in key financial metrics and segments. The company's focus on operational excellence and strategic initiatives has positioned it for continued success. While challenges exist, DuPont's ability to capitalize on opportunities and drive innovation bodes well for future growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Akzo Nobel NV

Albemarle

Air Products and Chemicals

Dow Inc

Eastman Chemical

LyondellBasell Industries

PPG Industries

Trecora Resources

Coronavirus Casts a Pall Over Diversified Chemical Industry

Unfortunate timing is taking its toll on DuPont.

Is DuPont Stock a Buy?

Cummins

Cummins has made N95 mask prototypes combining its filtration technology with DuPont's to address mask shortages in the wake of the COVID-19 pandemic.

Cummins and DuPont Partner to Make N95 Mask Alternative

BASF SE

Huntsman

A number of chemical companies are ramping up production to address the surging demand for health, hygiene and safety products.

Chemical Industry Leads the World in Fight Against Coronavirus

DuPont de Nemours, Inc. (NYSE: DD) shares are trading higher after the company announced it has reached a joint agreement with Toyobo Co.

Why DuPont's Stock Is Trading Higher Today

DuPont's (DD) Laminex Maxflow 4G is highly effective in lowering pentosan levels in all wort forms.

DuPont (DD) Introduces Laminex Maxflow 4G Enzyme in Australia

DuPont’s (NYSE: DD) stock has so far underperformed the broader markets in the recent coronavirus and oil price war related market crash. The stock has declined 38% since early February, as compared to a 28% fall for the S&P 500 (through March 20).

DuPont Down 40% Over The Last One Month, Will It Continue To Underperform?

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

Depend on DuPont: Profit From These Top-Ranked Stocks

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

5 DuPont-Tested High Quality Stock Picks as Virus Scare Spreads

At DuPont's largest manufacturing facility in Richmond, Virginia, CNBC got an inside look at how the company is making changes to its operations to accommodate the rise in demand for protective suits.

DuPont ramps up safety suit production as coronavirus causes shortages in China

DuPont  has brought back management veteran Edward Breen as its chief executive officer, in a move that the industrial materials maker is hoping will help lift sluggish sales since its split from DowDuPont Inc.

Breen to return as DuPont CEO

DuPont Inc. DD, -0.32% said Friday that Chief Executive Marc Doyle and Chief Financial Officer Jeanmarie Desmond are leaving the company, effective immediately.

DuPont CEO and CFO to leave company

Exxon Mobil

Which beaten-down company is the better buy?

Better Buy: ExxonMobil vs. DuPont

Have more faith in DuPont analysis than simple ROE calculation?  Bet on these five stocks.

Buy 5 Top-Ranked DuPont-Tested Stocks Amid Virus Scare

Caterpillar

ConocoPhillips

Valero Energy

Every day it seems that the market hits new all-time highs. Most targets for the S&P 500 from the start of the year have been blown through already, forcing Wall Street strategists to lift their targets higher, and we are in mid-February.

5 Contrarian Dividend Stocks to Buy as Market Rips to All-Time Highs

Expectations for 2020 were derailed by macroeconomic conditions.

Why Shares of DuPont Were Down in January

Let's see if DuPont de Numours (DD) stock is a good choice for value-oriented investors right now from multiple angles.

Is DuPont de Nemours (DD) a Good Pick for Value Investors?

The first quarter is going to be weaker than expected.

Why Shares of DuPont Fell Today

CFRA said Thursday it's sticking with a buy rating on shares of Dupont de Nemours Inc.

CFRA sticks with buy rating on DuPont after earnings, but lowers price target and estimates

DuPont de Nemours, Inc. (DD) CEO Marc Doyle on Q4 2019 Results - Earnings Call Transcript

DuPont (DD) faced challenges from weak automotive markets and lower nylon prices in Q4.

DuPont (DD) Misses Earnings and Revenue Estimates in Q4

DuPont's (DD) Q4 adjusted earnings of 95 cents per share missed the Zacks Consensus Estimate of 96 cents.

DuPont's (DD) Q4 Earnings and Sales Lag Estimates

Chemicals giant DuPont de Nemours DD, -0.43% said fourth-quarter earnings dropped to $176 million, or 24 cents a share, from $482 million, or 63 cents a share.

DuPont outlook below Wall Street estimates as EPS meets target

Deploy DuPont Strategy to Pick 4 Healthy Stocks

Axalta Coating Systems

Celanese

Let's take a look at how these chemical companies are poised ahead of their Q4 earnings release.

News for DuPont de Nemours Stock (DD)